
    
      It will conduct a clinical trial, double-blind, randomized and placebo control group female
      patients with 12 weeks of gestation have one or more risk factors for developing
      preeclampsia. 2 groups will be formed with 82 patients each, chance will determine the
      intervention (acetylsalicylic + L-arginine acetylsalicylic acid or acid + placebo). At the
      beginning and end of the intervention clinical and laboratory determinations, the end will be
      determined in both groups the incidence of preeclampsia, severity and number needed to treat
      is made. The data obtained were analyzed using SPSS statistical software version 22. It was
      considered statistically significant at p <0.05.
    
  